Abbott Laboratories Share Price

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 21:00:02 26/04/2024 BST 5-day change 1st Jan Change
107.5 USD +0.63% Intraday chart for Abbott Laboratories +0.23% -2.31%
Sales 2024 * 41.7B 3,339B Sales 2025 * 44.75B 3,583B Capitalization 187B 14,937B
Net income 2024 * 5.96B 477B Net income 2025 * 7.17B 574B EV / Sales 2024 * 4.61 x
Net Debt 2024 * 5.47B 438B Net cash position 2025 * 913M 73.11B EV / Sales 2025 * 4.15 x
P/E ratio 2024 *
31.4 x
P/E ratio 2025 *
26.8 x
Employees 114,000
Yield 2024 *
2.01%
Yield 2025 *
2.15%
Free-Float 86.77%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.63%
1 week+0.23%
Current month-5.39%
1 month-5.24%
3 months-4.00%
6 months+15.81%
Current year-2.31%
More quotes
1 week
105.56
Extreme 105.56
108.11
1 month
104.25
Extreme 104.25
113.66
Current year
104.25
Extreme 104.25
121.64
1 year
89.67
Extreme 89.674
121.64
3 years
89.67
Extreme 89.674
142.60
5 years
61.61
Extreme 61.61
142.60
10 years
36.00
Extreme 36
142.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 31/12/14
Director of Finance/CFO 51 31/12/96
Chief Tech/Sci/R&D Officer - 31/12/89
Members of the board TitleAgeSince
Director/Board Member 69 15/02/17
Director/Board Member 63 28/06/17
Director/Board Member 65 08/12/11
More insiders
Date Price Change Volume
26/04/24 107.5 +0.63% 3,575,566
25/04/24 106.9 -0.03% 3,112,495
24/04/24 106.9 -0.65% 5,052,691
23/04/24 107.6 +0.49% 3,849,589
22/04/24 107.1 -0.20% 4,948,315

Delayed Quote Nyse, April 26, 2024 at 09:00 pm

More quotes
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
107.5 USD
Average target price
126.3 USD
Spread / Average Target
+17.49%
Consensus